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Abstract
Objective: Work-related stress is a public health issue. Stress has multiple physical and psycho-
logical consequences, the most serious of which are increased mortality and cardiovascular
morbidity. The ThermStress protocol was designed to offer a short residential thermal spa
program for work-related stress prevention that is compatible with a professional context.
Methods: Participants will be 56 male and female workers aged 18 years or above. All partic-
ipants will undergo a 6-day residential spa program comprising psychological intervention, phys-
ical activity, thermal spa treatment, health education, eating disorder therapy and a follow-up. On
six occasions, participants’ heart rate variability, cardiac remodelling and function, electrodermal
activity, blood markers, anthropometry and body composition, psychology and quality of life will
be measured using questionnaires and bone parameters.
Results: This study protocol reports the planned and ongoing research for this intervention.
Discussion: The ThermStress protocol has been approved by an institutional ethics committee
(ANSM: 2016 A02082 49). It is expected that this proof of concept study will highlight the effect
of a short-term specific residential thermal spa program on the prevention of occupational
burnout and work-related stress. The findings will be disseminated at several research confer-
ences and in published articles in peer-reviewed journals.
Trial Registration: ClinicalTrials.gov (NCT 03536624, 24/05/2018)
Keywords
Stress, burnout, prevention, heart rate variability, spa bath, work, biomarkers
Date received: 12 November 2018; accepted: 3 June 2019
Introduction
Stress at work is both a public health issue
and an economic issue.1,2 The main conse-
quences of stress on health are increased
cardiovascular morbidity and mortality.3
Stress particularly affects autonomic ner-
vous system functioning.4 One of the main
cardiovascular health effects of stress is
deregulation of the sympathovagal bal-
ance.5 The most common measures of auto-
nomic nervous system activity are heart rate
variability (HRV) and electrodermal activi-
ty.6 Conveniently, there are non-intrusive
and pain-free measures of HRV and elec-
trodermal activity.7 Some genetic
polymorphisms linked with stress, such as
polymorphism of angiotensin converting
enzymes8–11 or of serotonin,12–14 are also
associated with cardiovascular risk. Stress
also causes arterial ischemic pathology15
via complex mechanisms involving changes
in arterial endothelial and microvascular
atherosclerosis.15 These microvascular
changes are linked to systemic inflammation
caused by stress,16 and changes within the
hypothalamic–pituitary axis (e.g. dehydro-
epiandrosterone sulphate (DHEAS),17,18
cortisol,17,18) and at a central level (e.g. neu-
ropeptide Y,19 brain-derived natriuretic
factor (BDNF),20). Stress can also lead to
obesity through inappropriate eating
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behaviours.21 Stressed individuals also find it
difficult to lose weight.22 Possible biological
mechanisms that link obesity and stress
involve the action of stress on leptin,23 an
anorectic hormone secreted by adipose
tissue and proposed as a biomarker of
stress.24 Stress, particularly stress at work,
is responsible for multiple somatic dis-
eases.25,26 For example, long-term mental
stress can have negative effects on bone
tissue, leading to osteoporosis and increased
bone fracture risk.27 Therefore, an assess-
ment of the association between bone
parameters and stress is needed. Moreover,
our program may modify bone parameters
and decrease bone fracture risk.6,28 More
interestingly, peripheral quantitative com-
puted tomography (pQCT) can be used to
measure muscles and intra- and inter-
muscular fat content,29–31 which can also
be modified by our program32 and may be
biomarkers of stress. Many stress bio-
markers are secreted by adipose tissue.33
Moreover, it has been demonstrated that
limb composition reflects total body compo-
sition, particularly fat.29–31
The psychological consequences of stress
are numerous and include dissatisfaction,
anxiety, depression and burnout.26 Non-
pharmacological methods of stress manage-
ment include psychological interventions,
physical activity34,35 and therapy for
stress-induced eating disorders.36 Several
psychological interventions have demonstrat-
ed positive effects on work-related stress,
such as cognitive-behavioural therapy,37
acceptance and commitment therapy38,39
and mindfulness.40,41 The benefits of any
type of physical activity on the physical
and mental health of individuals at any
age are indisputable.42
A recent systematic review highlighted
the effects of balneotherapy (bathing in
mineral springs) and spa therapy on stress
biomarkers. This review of 15 studies (684
subjects) emphasised the potential benefits
of such treatment on cortisol levels.43 In
France, there are five spa resorts that spe-
cialise in the treatment of psychosomatic
disorders. The usual duration for a residen-
tial thermal program in these resorts is
3 weeks. Previous research has demonstrat-
ed the positive effects of a 3-week spa ther-
apy intervention on burnout.44 However,
a shorter residential thermal spa program
may be more compatible with a profession-
al context because of the availability of
individuals. In addition, it would be useful
to focus on work-related stress prevention
(i.e. before the state of burnout).
Objective
This ThermStress proof of concept study was
developed to provide a new approach to the
management of stress disorders. The main
aim of the study is to assess the ability of a
short residential spa program to increase
HRV and manage work-related stress.
Methods
Protocol design: This 1-year study with
repeated measures on six occasions (inclu-
sion (one to five months prior to the begin-
ning of the spa program – M-1 to M-5), 6
days before the start (D-6), at the start
(D0), at the end of the spa program (D6),
at 6 months (M6) and at 12 months (M12)),
will allow us to explore the effect of a spe-
cific short-term residential thermal spa pro-
gram on the prevention of occupational
burnout and work-related stress in workers,
focusing on measures of well-being and car-
diovascular morbidity. Each participant
will undergo a 6-day residential spa pro-
gram comprising psychological interven-
tion, physical activity, thermal spa
treatment, health education and eating dis-
order therapy and a follow-up. Each partic-
ipant will be his/her own control and
we will compare variations in parameters
between intervention/control periods
(short-term variations: D6/D0 and D0/D6;
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long-term variations: inclusion/D0 com-
pared with D0/M6–M12) (Figure 1).
Selection criteria
Inclusion criteria: Volunteers will be workers
aged 18 years to retirement, with a stress
visual analogue scale score greater than
50mm, who wish to follow a residential spa
thermal program to manage work-related
stress. Participants must have had a stable
weight during the last 3 months and have
no uncontrolled cardiac, hepatic, renal or
endocrine diseases.32 In compliance with
human ethics guidelines, participants must
be covered by social health insurance and
must sign consent forms.
Exclusion criteria: Potential participants
will be excluded if major treatment and/or
protocol deviations are observed. Other exclu-
sion criteria are drugs and medical conditions
that significantly affect the primary outcome
of HRV (e.g. alpha or beta-blockers; arrhyth-
mias or conduction disorders such as bundle
branch block, atrioventricular heart block).45
Power analysis: The rationale for the
sample size estimation is based on HRV,
which is a biomarker of both stress and
morbidity/mortality.46,47 In particular,
within multiple parameters of HRV, we
considered log low frequency (LF)/high fre-
quency (HF) HRV for sample size calcula-
tion because it is the parameter that
traditionally represents sympathovagal bal-
ance, together with global HRV (see
description of LF/HF below in the descrip-
tion of the primary outcome section).4,46
A log LF/HF with low values is associated
with good autonomic nervous system
adaptation. Based on previous work,48 we
assumed a statistical power greater than
80%, a two-sided type I error of 5% and
an individual correlation coefficient set at
0.5 (each subject as his/her own control).
Based on the results of a pilot study, we
assumed that our response will promote
an absolute decrease of the log LF/HF by
20% (with a standard deviation of 45%).49
Therefore, we need to include n¼ 43 sub-
jects. Finally, to take into account lost to
follow-up, it is proposed to include
56 subjects.
Participants: Participants will be male
and female volunteers aged 18 years to
retirement. Following ethics committee
Figure 1. The ThermStress protocol. M-5: 5 months before the study; M-1: 1 month before the study.
HRV: heart rate variability.
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approval, and based on our calculation, 56
volunteers will be enrolled to account for
potential dropouts. All participants will be
given written information regarding the
project and will have to sign consent
forms before enrolment. Workers will be
recruited by the spa centres using flyers
and website announcements. Participants
will also be recruited using advertisements
provided by the CHU of Clermont-Ferrand
or by the Clermont Auvergne University.
Intervention programs: Participants will
attend a short-term residential spa program
lasting 6 days, which combines psychologi-
cal intervention, physical activity, thermal
spa treatment, health education and eating
disorder therapy. Physical activity will
be diverse (endurance, strength, circuit
training) to offer a personalised program
compatible with the desires of each partici-
pant. The benefits of all types of physical
activity on the physical and mental health
of individuals of any age are indisputable.
Psychological interventions will include var-
ious validated therapies for work-related
stress, such as cognitive-behavioural thera-
py, acceptance and commitment therapy
and mindfulness. Details on intervention
components are shown in Table 1 and the
agenda of the intervention program is shown
in Table 2.
Follow-up: After the intervention phase
of the study, participants will undergo a
1-year at-home follow-up.
Measurements: Each participant will
undergo a battery of tests (described
below). Data collection will be performed
six times, as previously described, except
for dual-energy X-ray absorptiometry
(DXA) and pQCT, which will be performed
at inclusion and after 12 months, and cardi-
ac remodelling and function, which will be
performed at inclusion and after 6 months.
Table 3 outlines all the study outcomes.
Primary outcome: To assess the ability
of a short residential spa program to
Table 1. Description of intervention components.
Intervention Dose Description
Spa treatment 6 120 min Spa treatment is a combination of spa bath (i.e. thermal
mud, jets), spa shower (i.e. hydromassage) and
body massage
Psychological
workshop
6 120 min Cognitive-behavioural therapy, acceptance and commitment
therapy, and mindfulness
Nutrition
workshop
4 90 min Participants must understand: concept of energetic balance,
calculation of energy intake, calculation of energy
expenditure (of physical activity, thermic effect of food),
effects of stress on energy intake (quantity and type of
intake), effects of physical activity on food intake regula-
tion, cooking sessions (to cook healthy meals)
þ1 breakfast During the breakfast session, participants will be provided
with information and advice related to the preparation of
a healthy breakfast
Supervised
physical activity
5 120 min Supervised physical activity will be delivered every day by a
qualified exercise physiologist. Physical activity will be
delivered as circuit training and will include resistance
and aerobic training
Biomarkers of
Stress workshop
1 90 min Understanding the purpose of biological changes owing to
stress and burnout
5134 Journal of International Medical Research 47(10)
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Table 3. Outcomes.
Variables Type of measure Measurement modality References
Biomarkers of stress
and cardiovascu-
lar risk
Skin conductance Wrist band electrodes
– Movisens
7
Blood flow velocity Laser speckle contrast imaging 78,79
Myocardial longitudinal strain Speckle-tracking
echocardiography
85,86
Genetic
polymorphisms
Polymorphism of angiotensin
converting enzymes
Blood cells 8–11
Polymorphism of serotonin Blood cells 12–14
Demographics Age, gender, qualification, per-
sonal work status, ethnicity,
life and occupational events
Questionnaire 4
Clinical measurements Height, weight, blood pressure,
heart rate, waist
circumference
Body composition Muscle mass, fat mass,
bone structure
Impedance meter 80
Densitometry X-ray absorption 6
Peripheral quantitative comput-
ed tomography
73–75
Quantitative ultrasound 81
Psychology and
quality of life
Depression Hamilton Anxiety Rating Scale 62
Anxiety Hamilton Anxiety Rating Scale 62
State–Trait Anxiety Inventory 60,61
General health General Health Questionnaire
(SF-12)
71
Stress, fatigue, sleep Visual analogue scale 4
Burnout Maslach Burnout Inventory 59
Mindfulness Freiburg Mindfulness Inventory 22,23
Coping Brief COPE Questionnaire 63
Emotions Emotion Regulation
Questionnaire
64
Perception of work Karasek’s Job Content
Questionnaire
65
Self-efficacy Perceived Self-efficacy Scale 66
Addiction to work Work Addiction Risk test 67
Alexithymia Toronto Alexithymia Scale 68,82,83
Illness perception Brief Illness Perception
Questionnaire, adapted for
stress at work
69,84
Metacognition Metacognitions
Questionnaire-30
70
Lifestyle E.g., smoking, alcohol consump-
tion, coffee consumption,
food intake
Questionnaires 4
Physical activity Recent Physical Activity
Questionnaire
72
(continued)
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manage work-related stress and increase
HRV, a biomarker of both stress and
morbidity/mortality.46,47
Heart rate variability: HRV parameters
will be assessed over 26 hours using a heart
rate transmitter belt simply positioned on
the chest, with a 26-hour recording time, a
beat per minute within a 25 to 240 range
and respiratory rate within a 3 to 70 range
(ZephyrTM BioHarnessTM BT, Zephyr
Technology, Annapolis, USA). The HRV
data will be examined according to the rec-
ommendations of the European Society of
Cardiology and the North American
Society (Task Force).50 HRV will be
explored in time and frequency domains.51
A methodology developed by our team will
also be used.52 Premature atrial and ventric-
ular beats will be automatically discarded
and visually checked. In the time domain,
R-R intervals, standard deviation of R-R
intervals, square root of the mean squared
difference of successive R-R intervals
(rMSSD), and number of adjacent N-N dif-
fering by more than 50 ms divided by the
total number of N-N intervals (pNN50)
will be analysed. The rMSSD and pNN50
are associated with HF power and
hence parasympathetic activity. In the spec-
tral domain, we will analyse LF power
(0.04–0.15Hz), an index of both sympathetic
and parasympathetic activity, and HF
power (0.15–0.4Hz), representing the most
efferent vagal (parasympathetic) activity to
the sinus node. Very low frequency (VLF;
0.003–0.04Hz) partially reflects thermoreg-
ulatory mechanisms, fluctuation in activity
of the renin–angiotensin system and the
function of peripheral chemoreceptors. LF
and HF will also be assessed in normalised
Table 3. Continued
Variables Type of measure Measurement modality References
Alloplastic
load
HbA1c, HDLc and LDLc, TG Ethylenediaminetetraacetic
acid tube
6
Cortisol Dry tube, serum isolation and
deep-freezing
17,85
DHEAS Dry tube, serum isolation
and deep-freezing
17,85
Leptin Dry tube, serum isolation and
deep-freezing
6
BDNF Dry tube, serum isolation and
deep-freezing
20,86,87
Pro-inflammatory cytokines:
IL-1b, IL-6, IL-1, TNFa
Dry tube, serum isolation
and deep-freezing
6
NPY Dry tube, serum isolation and
deep-freezing
19
Telomere length Blood; Southern blot or
polymerase chain
reaction analyses
88
Heart rate variability Holter 89
Skin conductance –
electrodermal activity
Wristband electrodes 89
A total of 25 mL of blood will be sampled (i.e. 100 mL in 1 year). HbA1c: haemoglobin A1c; HDLc: high-density lipoprotein
cholesterol; LDLc: low-density lipoprotein cholesterol; TG: triglycerides; DHEAS: dehydroepiandrosterone sulphate;
BDNF: brain-derived neurotrophic factor; IL: interleukin; TNFa: tumour necrosis factor a; NPY: neuropeptide Y.
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units (nu), which represent the relative value
of each power component in proportion to
the total power minus the VLF component.
Thus, LFnu and HFnu are considered to
represent best sympathetic and parasympa-
thetic activity, respectively.53 The LF/HF
ratio (i.e. the sympathovagal balance) will
also be calculated.46
Secondary outcomes: Secondary out-
comes will be (1) to demonstrate an
improvement in perceived stress and other
stress biomarkers following the short resi-
dential spa program, (2) to study the influ-
ence of genetic polymorphisms on stress and
on the response to our stress management
program, (3) to examine the relationship
between subjective (questionnaire responses)
and objective (biomarker) variables, (4) to
propose a salient biomarker or a salient
composite index of biomarkers of stress
and (5) to study the effect on stress of obser-
vance to the program at follow-up.
Anthropometry: The following anthropo-
metric measures will be obtained according
to the recommendations of the
International Society for the Advancement
of Kinanthropometry54: standing height
(m) and body mass (kg), waist circumfer-
ence (cm), and lower limb bone length/
breadth (cm).54
Body composition: Body composition
(muscle mass and fat mass) will be mea-
sured using DXA (DXA, QDR-4500A,
Hologic, Inc., Waltham, MA, USA).6 and
impedancemeter.80
Biomarkers of stress and cardiovascular
risk: Skin conductance will be measured
using wristband electrodes with sampling
rates at 2, 4, 8, 16 and 32Hz during
phases 1 to 3. The SC sensor (Q-SensorVR -
AffectivaVR , Massachusetts Institute of
Technology, USA) is set on a wristband
and has a 24-hour battery life when logging.
In addition, it measures wrist movements
with a built-in 3-axis accelerometer.
Blood flow velocity and myocardial lon-
gitudinal strain will be measured using
speckle echocardiography (Vivid Q, GE
Healthcare Biosciences, Piscataway, NJ,
USA). All 2-dimensional (2D), time-
motion, Doppler and 2D-strain acquisitions
and measurements will be performed
according to recent guidelines.55,56 Left ven-
tricular (LV) volumes and ejection fractions
will be measured using Simpson’s biplane
method.57 LV mass will be calculated using
the Devereux formula and indexed for
height (Cornell adjustment). Pulsed
Doppler LV transmitral velocities, including
early and atrial waves, will be obtained using
the apical 4-chamber view. Tissue Doppler
imaging measures of myocardial systolic,
early diastolic and atrial velocities will be
assessed at the mitral annulus level in the
apical 4- and 2-chamber views. The early
transmitral flow velocity to the early diastol-
ic tissue velocity ratio was used as an index
of LV filling pressure. 58 Left atrium volume
will be assessed using apical 4- and 2-cham-
ber views. A graduation of LV diastolic dys-
function will be obtained according to recent
guidelines. 58 2D cine-loops (frame rate >70
ips) of at least five cycles will be recorded in
the short-axis views (base, mid, apex), as
well as in the apical 4-, 3- and 2-chamber
views. 2D-strain analysis will be performed
post-processing using EchoPAC 201TM
software (GE Healthcare Biosciences,
Piscataway, NJ, USA). Longitudinal and
circumferential strains and strain rates, as
well as apex and base rotations, will be
directly obtained from the six-segment
model. Twist mechanics will be computed
from apical and basal rotational data using
dedicated software (Scilab, Paris, France).
For each view, the three cardiac cycles dis-
playing the best image quality will be select-
ed. Blood pressure and heart rate will be
continuously monitored, and the systolic
meridional wall stress, an index of afterload,
will be calculated. LV end-diastolic volumes
will also be obtained as a preload index.
Endocrine assays: Blood samples will be
collected by a qualified paediatric nurse
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after participants have fasted overnight.
Blood will be collected using a venepunc-
ture at the brachial vein. After collection,
blood will be centrifuged and aliquots will
be stored (80) for subsequent analysis.
(triglycerides,6 cholesterol,6 low-density
lipoprotein cholesterol,6 high-density lipo-
protein cholesterol,6 glycaemia,6 insulin,6
ultra-sensitive C-reactive protein,6 corti-
sol,17,18 DHEAS17,18) as well as all
other biochemical measures (leptin,6
brain-derived neurotrophic factor,20,87
interleukin-1b,6 interleukin-6,6 interleukin-
1,6 tumour necrosis factor a,6 and neuro-
peptide Y19) will be assessed in the bio-
chemistry laboratory of Clermont-Ferrand
University Hospital. All analyses will be
conducted by the same technician.
Polymorphism of the angiotensin convert-
ing enzyme8-11 and polymorphism of sero-
tonin12-14 will be measured from blood
cells, as welll as telomere length.88
Complementary measures: Questionnaire
measures of the following variables will be
obtained: stress and fatigue (visual analogue
scale of 100 mm),4 burnout (Maslach
Burnout Inventory),59 depression and anxi-
ety (Hospital Anxiety and Depression
Scale,60 State–Trait Anxiety Inventory
(STAI-Y),61 7-item Hamilton Anxiety
Rating Scale),62 mindfulness (Freiburg
Mindfulness Inventory),22 coping strategies
(Brief COPE Questionnaire),63 emotions
(Emotion Regulation Questionnaire),64 per-
ception of work (Karasek’s Job Content
Questionnaire),65 self-efficacy (Perceived
Self-efficacy Scale),66 addiction to work
(Work Addiction Risk test),67 alexithymia
(20-item Toronto Alexithymia Scale),68 ill-
ness perception (Brief Illness Perception
Questionnaire, adapted for stress at
work),69 metacognition (Metacognitions
Questionnaire-30),70 general health (12-item
General Health Questionnaire (SF-12)),71
lifestyle (e.g. smoking, alcohol consump-
tion)4 and physical activity (Recent
Physical Activity Questionnaire).72
Bone parameters: Bone microarchitec-
ture will be measured using pQCT (XCT
3000 Stratec Medizintechnik Pforzheim,
Germany).73–75 Bone mineral content
(BMC) (g/cm), volumetric cortical and tra-
becular BMC (mg/cm3), total area (mm2),
cortical and trabecular area (mm2) and
density (g/cm2), and bone strength (mm3)
will be assessed at the distal (4%) and prox-
imal (66%) sites of the non-dominant tibia
and radius. A planar scout scan was first
conducted to determine the anatomical ref-
erence line for both the radius and tibia.
Tomographic slices of 2 mm thickness
were obtained at the 4% and 66% sites
measured distally. Scan speed and voxel
size were 20 mm/s and 0.4 mm, respectively.
To ensure measurement quality, calibration
checks will be performed by scanning a
standard phantom with known densities
prior to each scan. To calculate BMC, vol-
umetric cortical BMC, volumetric trabecu-
lar BMC, cortical bone area, cortical
density, trabecular area, trabecular density
and stress strain index will be analysed
using the Stratec pQCT manufacturer’s
software. Contour mode 1 with a threshold
of 180 mg/cm3 will be used to separate soft
tissue and bone to analyse trabecular bone.
Cortical bone will be identified and
removed using a constant default threshold
of 710 mg/cm3. A contour mode 3 with peel
mode 1 at a threshold of 40 mg/cm3 will be
used to assess muscle and fat cross-
sectional areas.
Bone densitometry will be conducted
using DXA (QDR-4500A, Hologic, Inc.,
Waltham, MA, USA). Bone mineral densi-
ty (g/cm2), BMC (g) and bone area (cm2)
will be determined for each participant.
The DXA measurements will be taken for
the whole body, the lumbar spine (L2–L4)
and the non-dominant hip (including the
femoral neck, and the trochanteric and
intertrochanteric regions). All DXA scans
will be conducted by the same technician
and quality assurance checks will be
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performed routinely. The in-vivo coefficient
of variation is 0.5%.
Statistical analysis: Statistical analysis
will be performed using Stata software
(version 13; StataCorp LP, College
Station, TX, USA). All statistical tests will
be two-sided and p< 0.05 will be considered
significant. After testing for normal distri-
bution (Shapiro–Wilk test), data will be
treated either by parametric or non-
parametric analyses according to statistical
assumptions.
Mixed models will be used to analyse
longitudinal data for fixed effects (before
and after the residential thermal program),
time-point evaluation and group time
interaction taking into account between-
and within-participant variability (as
random effects). A Sidak’s type I error cor-
rection will be applied to take into account
multiple comparisons. The normality of
residuals will be examined using the
Shapiro–Wilk test. If necessary, a logarith-
mic transformation will be used to achieve
normality for the dependent outcome.
Multivariable analyses will be carried out
with adjustment for covariates fixed accord-
ing to epidemiological relevance and physi-
cal activity. Particular attention will be paid
to the covariates ‘time between inclusion
and beginning of the intervention’ (variable
for each subject) and ‘time between begin-
ning of the intervention and the follow-up’
(fixed for each subject).
Analysis of non-repeated data will be
performed using analysis of variance
(ANOVA) or Kruskal–Wallis tests. When
appropriate (omnibus p-value less than
0.05), a post-hoc test for multiple compar-
isons will be used: the Tukey–Kramer test
following ANOVA and the Dunn test fol-
lowing the Kruskal–Wallis test. Categorical
variables will be compared using chi-
squared or Fisher’s test. The Marascuilo
procedure will be performed for multiple
comparisons. Relations between quantita-
tive outcomes will be analysed using
correlation coefficients (Pearson or
Spearman, according to statistical distribu-
tion). Fisher’s z transformation and
William’s T2 statistic will be used to com-
pare correlations between variables and
within a single group of subjects.
A sensitivity analysis will be used to
study the statistical nature of missing data
(random or non-random); that is, baseline
characteristics of participants with com-
plete follow-up and those lost to follow-up
will be compared using the aforementioned
statistical tests. Even if random-effects
models permit the analysis of data when a
participant is lost to follow-up, the most
appropriate imputation data method
according to the statistical nature of miss-
ing data (multiple imputation data, last
observation carried out (LOCF)) will be
applied. More precisely, if a participant
drops out of the study before it ends, then
his or her last observed score on the depen-
dent variable is used for all subsequent (i.e.
missing) observation points if the LOCF
imputation approach is used.
Confidentiality:Data will be stored in the
principal investigator’s office on a
password-protected computer only accessi-
ble to members of our research team. In the
electronic database, participants’ names
will be replaced with numeric identity
codes. Blood samples will also be labelled
with the numeric identity codes and samples
will be stored in our laboratories. Only
aggregate results will be reported, ensuring
participants’ anonymity.
Radiation: Both DXA and pQCT pro-
vide measures of body composition and
bone properties by exposing participants
to low-level radiation: 0.0056 mSv from
DXA scans (whole body, lumbar and hip)
and 0.0014 mSv from pQCT scans (tibia
and radius measures).76 Over the duration
of the study, the effective dose of 0.014 mSv
will be administered.
Ethics approval and consent to partici-
pate: The ThermStress protocol complies
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with the ethics guidelines for clinical
research (Declaration of Helsinki) and has
been approved by an ethics committee (CPP
Tours Re´gion centre Ouest 1, France -
ANSM: 2016 A02082 49). The protocol
has also been registered with the database
ClinicalTrials.gov (NCT03536624). In
accordance with ethical considerations, the
chief investigator will be responsible for
ensuring that participants understand the
potential risks and benefits of study partic-
ipation. Moreover, the chief investigator
will be responsible for obtaining written con-
sent from participants. The results will be
disseminated at several research conferences
and published in peer-reviewed journals.
Concluding remarks
The ThermStress protocol was designed to
provide a better understanding of the effect
of a short residential spa program to
improve HRV and prevent work-related
stress. The idea is to adapt a 3-week thermal
cure for occupational burnout to a 6-day
program, which is more accessible to work-
ers and hopefully will produce similar
results for work-related stress and burnout
prevention. The long-term success of life-
style interventions such as those proposed
in work-related stress prevention depends
on treatment observance (psychology, phys-
ical activity, nutrition).77 We previously
demonstrated that spa programs can play
a major role in prompting sustainable life-
style changes.28 This shorter program may
lead to better treatment observance during
the 1-year follow-up, as psychological inter-
ventions, physical activity and diet will be
supervised in the spa resort and participants
will be accompanied by health care profes-
sionals. Findings from this protocol are
expected to offer a more appropriate thermal
program for burnout and work-related stress
prevention that is accessible to the public.
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